Nanoengineering of doxorubicin delivery systems with functionalized maghemite nanoparticles

Colloids and Surfaces B: Biointerfaces

Volumn 111, Issue , 2013, Pages 88-96

  Rudzka, Katarzyna ^a   Viota, Julián L ^b   Munoz Gamez J A ^b   Carazo, A ^b   Ruiz Extremera, A ^b   Delgado, Ángel V ^a  

^a UNIVERSITY OF GRANADA   (Spain)

^b HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

Author keywords

Cancer chemotherapy; Doxorubicin; Drug delivery systems; Gold layer; Maghemite nanoparticles; Silica coating

Indexed keywords

CANCER CHEMOTHERAPY; DOXORUBICIN; DRUG DELIVERY SYSTEM; GOLD LAYER; MAGHEMITE NANOPARTICLE; SILICA COATINGS;

ASSAYS; BIOCOMPATIBILITY; CELLS; CHEMICAL MODIFICATION; CHEMOTHERAPY; CYTOLOGY; CYTOTOXICITY; DRUG DELIVERY; GOLD; GOLD COATINGS; GOLD DEPOSITS; MEDICAL APPLICATIONS; NANOCOMPOSITES; SILICA; SUPERPARAMAGNETISM; TOXICITY;

NANOPARTICLES;

(3 AMINOPROPYL)TRIMETHOXYSILANE; DOXORUBICIN; GOLD; NANOCOMPOSITE; SILANE DERIVATIVE; SILICON DIOXIDE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; UNCLASSIFIED DRUG; FERRIC ION; FERRIC OXIDE; NANOPARTICLE; NANOSPHERE;

ARTICLE; CANCER CELL; CELL NUCLEUS; CELL SURVIVAL; CHEMICAL MODIFICATION; COLON CANCER; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG UPTAKE; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER CANCER; NANOENGINEERING; PRIORITY JOURNAL; ADSORPTION; CELL DEATH; CHEMISTRY; DRUG EFFECTS; KINETICS; NANOTECHNOLOGY; PROCEDURES; TUMOR CELL LINE; ULTRASTRUCTURE;

ADSORPTION; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; DOXORUBICIN; DRUG DELIVERY SYSTEMS; FERRIC COMPOUNDS; HUMANS; KINETICS; NANOPARTICLES; NANOSPHERES; NANOTECHNOLOGY; SILICON DIOXIDE;

EID: 84879465337     PISSN: 09277765     EISSN: 18734367     Source Type: Journal    
DOI: 10.1016/j.colsurfb.2013.05.010     Document Type: Article

References (57)

1. Nanoparticulate Drug Delivery Systems (Drugs and the Pharmaceutical Science, vol. 166) 2007, Informa Healthcare Inc., New York, (Chapter 1). D. Thassu, Y. Pathak, M. Deleers in, D. Thassu, M. Deleers, Y. Pathak (Eds.).
2. Dobson J. Drug Dev. Res. 2006, 67:55.
3. Sun C., Lee J.S.H., Zhang M. Adv. Drug Deliv. Rev. 2008, 60:1252.
4. Widder K.J., Senyei A.E., Ranney D.F. Adv. Pharmacol. Chemother. 1979, 16:213.
5. Senyei A., Widder K., Czerlinski C. J. Appl. Phys. 1978, 49:3578.
6. Singh N., Manshian B., Jenkins G.J.S., Griffiths S.M., Williams P.M., Maffeis T.G.G., Wright C.J., Doak S.H. Biomaterials 2009, 30:3891.
7. Naqvi S., Samim M., Abdin M.Z., Ahmed F.J., Maitra A.N., Prashant C.K., Dinda A.K. Int. J. Nanomed. 2010, 5:983.
8. Balasubramanyam A., Sailaja N., Mahboob M., Rahman M.F., Hussain S.M., Grover P. Toxicol. In Vitro 2010, 24:1871.
9. Gupta A.K., Naregalkar R.R., Vaidya V.D., Gupta M. Nanomedicine 2007, 2:23.
10. Soenen S.J.H., Himmelreich U., Nuytten N., De Cuyper M. Biomaterials 2011, 32:195.
11. Sun J., Zhou S., Hou P., Yang Y., Weng J., Li X., Li J. Biomed. Mater. Res. A 2007, 80:333.
12. Viota J.L., Rudzka K., Trueba A., Torres-Aleman I., Delgado A.V. Langmuir 2011, 27:6426.
13. Schlorf T., Meincke M., Kossel E., Glüer C.C., Jansen O., Mentlein R. Int. J. Mol. Sci. 2011, 12:12.
14. McBain S.C., Yiu H.H.P., Dobson J. Int. J. Nanomed. 2008, 3:169.
15. Schroeder U., Sommerfeld P., Ulrich S., Sabel B.A. J. Pharm. Sci. 1998, 87:1305.
16. Lin B.L., Shen X.D., Cui S. Biomed. Mater. 2007, 2:132.
17. Jarzyna P.A., Skajaa T., Gianella A., Cormode D.P., Samber D.D., Dickson S.D., Chen W., Griffioen A.W., Fayad Z.A., Mulder W.J.M. Biomaterials 2009, 30:6947.
18. Pankhurst Q.A., Connolly J., Jones S.K., Dobson J. J. Phys. D: Appl. Phys. 2003, 36:R167.
19. Gupta A.K., Curtis A.S.C. J. Mater. Sci. Mater. Med. 2004, 15:493.
20. Sonvico F., Mornet S., Vasseur S., Dubernet C., Jaillard D., Degrouard J., Hoebeke J., Duguet E., Colombo P., Couvreur P. Bioconjugate Chem. 2005, 16:1181.
21. Berry C., Curtis A.S.G. J. Phys. D: Appl. Phys. 2003, 36:R198.
22. Mahmoudi M., Laurent S., Shokrgozar M.A., Hosseinkhani M. ACS Nano 2011, 5:7263.
23. Szalay B., Tátrai E., Nyíro G., Vezér T., Dura G. J. Appl. Toxicol. 2012, 32:446.
24. Laurent S., Burtea C., Thirifays C., Häfeli U.O., Mahmoudi M. PLoS ONE 2011, 7:e29997.
25. Sharifi S., Behzadi S., Laurent S., Forrest L., Stroeve P., Mahmoudi M. Chem. Soc. Rev. 2012, 41:2323.
26. Arruebo M., Fernández-Pacheco R., Ibarra M.R., Santamaría J. NanoToday 2007, 2:22.
27. Arruebo M., Galán M., Navascués N., Téllez C., Marquina C., Ibarra M.R., Santamaría J. Chem. Mater. 2006, 18:1911.
28. Zhao W., Gu J., Zhang L., Chen H., Shi J. J. Am. Chem. Soc. 2005, 127:8916.
29. Chen J.F., Ding H.M., Wang J.X., Shao L. Biomaterials 2004, 25:723.
30. Zhu Y., Shi J., Shen W., Dong X., Feng J., Ruan M., Li Y. Angew. Chem. 2005, 117:5213.
31. Barbé C., Bartlett J., Kong L., Finnie K., Qiang Lin H., Larkin M., Calleja S., Bush A., Calleja G. Adv. Mater. 2004, 16:1959.
32. Liu H., Chen D., Li L., Liu T., Tan L., Wu X., Tang F. Angew. Chem. Int. Ed. 2011, 50:891.
33. Andersson J., Rosenholm J., Lindén M. Chapter - mesoporous silica: an alternative diffusion controlled drug delivery system topics. Multifunctional Biomaterials and Devices 2008, N. Ashammakhi (Ed.).
34. Slowing I.I., Trewyn B.G., Giri S., Lin V.S.Y. Adv. Funct. Mater. 2007, 17:1225.
35. Slowing I.I., Vivero-Escoto J.L., Wu C.W., Lin V.S.Y. Adv. Drug Deliv. Rev. 2008, 60:1278.
36. Zhao Y., Trewyn B.G., Slowing I.I., Lin V.S.Y. J. Am. Chem. Soc. 2009, 131:8398.
37. Li Z.Z., Wen L.X., Shao L., Chen J.F. J. Control. Release 2004, 98:245.
38. Paciotti G.F., Kingston D.G.I., Tamarkin L. Drug Dev. Res. 2006, 67:47.
39. Lopez-Viota J., Mandal S., Delgado A.V., Toca-Herrera J.L., Moller M., Zanuttin F., Balestrino M., Krol S. J. Colloid Interface Sci. 2009, 1:215.
40. Liu H., Chen D., Li L., Liu T., Tan L., Wu I., Tang F. Angew. Chem. Int. Ed. 2011, 50:891.
41. Bikram M., Gobin A.M., Whitmire R.E., West J.L. J. Control. Release 2007, 123:219.
42. Connor E.E., Mwamuka J., Gole A., Murphy C.J., Wyatt M.D. Small 2005, 1:325.
43. Ghosh P., Han G., De M., Kim C.K., Rotello V.M. Adv. Drug Deliv. Rev. 2008, 60:1307.
44. Salgueiriño-Maceira V., Correa-Duarte M.A., Farle M., López-Quintela A., Sieradzki K., Diaz R. Chem. Mater. 2006, 18:2701.
45. Rudzka K., Delgado A.V., Viota J.L. Mol. Pharmaceut. 2012, 9:2017.
46. Pham T., Jackson J.B., Halas N.J., Lee T.R. Langmuir 2002, 18:4915.
47. Busbee B.D., Obare S.O., Murphy C.J. Adv. Mater. 2003, 15:414.
48. Valenzuela M.T., Nunez M.I., Villalobos M., Siles E., Olea N., Pedraza V., McMillan T.J., Ruiz de Almodovar J.M. Anticancer Drugs 1995, 6:749.
49. Decuzzi P., Godin B., Tanaka T., Lee S.-Y., Chaippini C., Liu X., Ferrari M. J. Control. Release 2010, 141:320.
50. Barreto J.A., O'Malley W., Kubeil M., Graham B., Stephan H., Spizzia L. Adv. Mater. 2011, 23:H18.
51. Mahmoudi M., Sant S., Wang B., Laurent S., Sen T. Adv. Drug Deliv. Rev. 2011, 63:24.
52. Lu A.H., Salabas E.L., Schuth F. Angew. Chem. Int. Ed. 2007, 46:1222.
53. van de Hulst H.C. Light Scattering by Small Particles 1981, Dover, New York, (Chapter 19).
54. Thode K., Müller R.H., Kresse M. J. Pharm. Sci. 2000, 89:1317.
55. Tapeinos C., Efthimiadou E.K., Boukos N., Charitidis C.A., Koklioti M., Kordas G. J. Mater. Chem. B 2013, 1:194-203.
56. Higuchi T. J. Pharm. Sci. 1961, 52:874.
57. Morales M.E., Gallardo V., Calpena A.C., Domenech J., Ruiz M.A. J. Control. Release 2004, 95:75.